SCHEMBL8769199

SCHEMBL8769199

COC(=O)C1CCc2cc(OCc3ccccc3)ccc2C1

nearest known ligand 0.69

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
FAAH O00519 17/20 0.69
FFAR1 O14842 1/20 0.52
HRH3 Q9Y5N1 2/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9022793 0.95 FAAH (0.63) FAAHHRH3
SCHEMBL12472053 0.90 FAAH (0.59) FAAHHRH3
SCHEMBL6751368 0.89 FAAH (0.67) FAAHFFAR1HRH3
SCHEMBL346315 0.89 FAAH (0.58) FAAH
SCHEMBL630776 0.89 FAAH (0.64) FAAHFFAR1
SCHEMBL6747894 0.88 FAAH (0.68) FAAHFFAR1HRH3
SCHEMBL345723 0.85 FAAH (0.53) FAAHFFAR1
SCHEMBL8536279 0.84 FAAH (0.62) FAAH
SCHEMBL346357 0.84 FAAH (0.54) FAAH
SCHEMBL629707 0.83 FAAH (0.60) FAAHHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-7224005-A None JP disclosed
US-9504675-B2 Alpha-ketoheterocycles and methods of making and using THE SCRIPPS RESEARCH INSTITUTE (US) 2016-11-29 US disclosed
US-9504675-B2 Alpha-ketoheterocycles and methods of making and using THE SCRIPPS RESEARCH INSTITUTE (US) 2016-11-29 US disclosed
US-9504675-B2 Alpha-ketoheterocycles and methods of making and using THE SCRIPPS RESEARCH INSTITUTE (US) 2016-11-29 US disclosed
EP-2670245-B1 ALPHA-KETOHETEROCYCLES AND METHODS OF MAKING AND USING SCRIPPS RESEARCH INST (US) 2015-09-09 EP disclosed
EP-2670245-B1 ALPHA-KETOHETEROCYCLES AND METHODS OF MAKING AND USING SCRIPPS RESEARCH INST (US) 2015-09-09 EP disclosed
US-20130338196-A1 ALPHA-KETOHETEROCYCLES AND METHODS OF MAKING AND USING THE SCRIPPS RESEARCH INSTITUTE (US) 2013-12-19 US disclosed
EP-0617109-B1 Liquid crystal material, liquid crystal composition and liquid crystal element MITSUI PETROCHEMICAL IND (JP) 1997-09-17 EP disclosed
JP-H07224005-A CARBOXYLIC ESTES AND LIQUID CRYSTAL ADDITIVES MITSUI PETROCHEM IND LTD 1995-08-22 JP disclosed
US-5422039-A Having a chiral center-containing a tetralinylene ring as well as a second chiral center; cells having high temperature operating range; high switching speed, low voltage and stable contrast MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1995-06-06 US disclosed
EP-0617109-A1 Liquid crystal material, liquid crystal composition and liquid crystal element MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) 1994-09-28 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130338196-A1 ALPHA-KETOHETEROCYCLES AND METHODS OF MAKING AND USING FAAH, FAAH2, CNR2 FAAH 1/4885FFAR1 89/4885HRH3 100/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.